This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 1974 Apr;4(2):138-43.

doi: 10.1111/j.1445-5994.1974.tb03162.x.

Variability of L-dopa absorption in man

D N Wade, P T Mearrick, D J Birkett, J Morris

PMID: 4528851
DOI: 10.1111/j.1445-5994.1974.tb03162.x

Comparative Study

Variability of L-dopa absorption in man

D N Wade et al. Aust N Z J Med. 1974 Apr.

. 1974 Apr;4(2):138-43.

doi: 10.1111/j.1445-5994.1974.tb03162.x.

Authors

D N Wade, P T Mearrick, D J Birkett, J Morris

PMID: 4528851
DOI: 10.1111/j.1445-5994.1974.tb03162.x

No abstract available

PubMed Disclaimer

Similar articles

Metoclopramide, gastric emptying and L-dopa absorption.
Mearrick PT, Wade DN, Birkett DJ, Morris J. Mearrick PT, et al. Aust N Z J Med. 1974 Apr;4(2):144-8. doi: 10.1111/j.1445-5994.1974.tb03163.x. Aust N Z J Med. 1974. PMID: 4528645 No abstract available.
Effect of anticholinergic drugs on gastro-intestinal absorption of L-dopa in rats and in man.
Algeri S, Cerletti C, Curcio M, Morselli PL, Bonollo L, Buniva G, Minazzi M, Minoli G. Algeri S, et al. Eur J Pharmacol. 1976 Feb;35(2):293-9. doi: 10.1016/0014-2999(76)90231-4. Eur J Pharmacol. 1976. PMID: 1248506
Intestinal absorption of levodopa in man.
Gundert-Remy U, Hildebrandt R, Stiehl A, Weber E, Zürcher G, Da Prada M. Gundert-Remy U, et al. Eur J Clin Pharmacol. 1983;25(1):69-72. doi: 10.1007/BF00544017. Eur J Clin Pharmacol. 1983. PMID: 6617727
Pharmacokinetics of levodopa.
Nutt JG, Fellman JH. Nutt JG, et al. Clin Neuropharmacol. 1984;7(1):35-49. doi: 10.1097/00002826-198403000-00002. Clin Neuropharmacol. 1984. PMID: 6367973 Review. No abstract available.
Bioavailability of drugs (first of two parts).
Koch-Weser J. Koch-Weser J. N Engl J Med. 1974 Aug 1;291(5):233-7. doi: 10.1056/NEJM197408012910505. N Engl J Med. 1974. PMID: 4600408 Review. No abstract available.

See all similar articles

Cited by

A pharmacokinetic model to predict the PK interaction of L-dopa and benserazide in rats.
Grange S, Holford NH, Guentert TW. Grange S, et al. Pharm Res. 2001 Aug;18(8):1174-84. doi: 10.1023/a:1010935228654. Pharm Res. 2001. PMID: 11587490
Plasma dopa concentrations after different preparations of levodopa in normal subjects.
Morris JG, Parsons RL, Trounce JR, Groves MJ. Morris JG, et al. Br J Clin Pharmacol. 1976 Dec;3(6):983-90. doi: 10.1111/j.1365-2125.1976.tb00347.x. Br J Clin Pharmacol. 1976. PMID: 22216519 Free PMC article. Clinical Trial.
The effect of selegiline on the peripheral pharmacokinetics of levodopa in young volunteers.
Roberts J, Waller DG, O'Shea N, Macklin BS, Renwick AG. Roberts J, et al. Br J Clin Pharmacol. 1995 Oct;40(4):404-6. doi: 10.1111/j.1365-2125.1995.tb04564.x. Br J Clin Pharmacol. 1995. PMID: 8554944 Free PMC article. Clinical Trial.
Model-based optimization of controlled release formulation of levodopa for Parkinson's disease.
Arav Y, Zohar A. Arav Y, et al. Sci Rep. 2023 Sep 22;13(1):15869. doi: 10.1038/s41598-023-42878-5. Sci Rep. 2023. PMID: 37739971 Free PMC article.
"On-off" phenomenon in Parkinson's disease: correlation to the concentration of dopa in plasma.
Eriksson T, Magnusson T, Carlsson A, Linde A, Granérus AK. Eriksson T, et al. J Neural Transm. 1984;59(3):229-40. doi: 10.1007/BF01250010. J Neural Transm. 1984. PMID: 6429277

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Wiley